Accolade Inc is a technology-driven healthcare company that offers personalized health and benefits solutions
The company leverages data analytics and artificial intelligence to provide individuals and employers with tailored guidance in navigating complex healthcare systems. By pairing users with dedicated health assistants, Accolade aims to simplify healthcare decisions, enhance user experience, and improve health outcomes while helping organizations manage costs associated with employee health benefits. Through its innovative platform, the company optimizes access to care, navigates insurance options, and supports overall wellness initiatives.
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.
Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025.
Accolade Inc shares are tanking in Thursday's after-hours session after the company reported financial results for its fiscal first quarter and issued weak guidance.
